v3.25.2
Collaboration, License, and Other Agreements - Other Narrative (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended
Jun. 30, 2025
Sep. 30, 2025
Disaggregation of Revenue [Line Items]    
Payment to acquire intangible asset $ 155.0  
Hanosh Pharmaceutical Group Company Limited | Forecast    
Disaggregation of Revenue [Line Items]    
Up-front payment to acquire license rights   $ 80.0